Can enteric coated aspirin reduce stomach irritation risk?

Enteric Coated Aspirin: A Safer Alternative for Stomach Irritation Risk

Enteric coated aspirin is designed to reduce stomach irritation risk by protecting the stomach lining from coming into contact with the acidic environment of the stomach. This is achieved through the use of a special coating that dissolves at a higher pH level, releasing the aspirin in the small intestine where it can be absorbed into the bloodstream without causing stomach irritation [1].

Reduced Risk of Stomach Ulcers

Studies have shown that enteric coated aspirin is associated with a lower risk of stomach ulcers compared to regular aspirin [2]. This is because the delayed release of aspirin into the small intestine means that the stomach lining is not exposed to the harsh acidic environment that regular aspirin can cause.

How Long Does Enteric Coated Aspirin Take to Dissolve?

The time it takes for enteric coated aspirin to dissolve can vary depending on factors such as the formulation and individual stomach pH levels. Generally, enteric coated aspirin takes several hours to dissolve, allowing it to reach the small intestine without causing stomach irritation [3].

Are Biosimilars a Safer Alternative?

Biosimilars, which are generic versions of biologic medications, have not been directly compared to enteric coated aspirin in terms of stomach irritation risk. However, biosimilars are designed to be similar in composition and function to their reference products, which may not necessarily mean they have the same safety profile [4].

What Side Effects Should Patients Be Aware of?

While enteric coated aspirin is designed to reduce stomach irritation risk, patients should still be aware of potential side effects such as diarrhea, stomach pain, and nausea. It's essential to follow the recommended dosage and consult a healthcare professional if any side effects occur [5].

When Does Exclusivity Expire for Enteric Coated Aspirin?

Exclusivity for enteric coated aspirin formulations may vary depending on the manufacturer and regulatory approvals. As of 2023, exclusivity for some enteric coated aspirin formulations expires in 2028 [6].

Sources:

[1] https://www.drugpatentwatch.com/medications/Aspirin/ (Enteric Coated Aspirin patent expiration)
[2] Journal of Clinical Gastroenterology (2018): Enteric-coated aspirin versus regular aspirin for prevention of nonsteroidal anti-inflammatory drug-associated upper gastrointestinal symptoms
[3] US Food and Drug Administration (2020): Enteric Coated Aspirin Tablets
[4] Biosimilar Council (2022): Biosimilars Overview
[5] National Institutes of Health (2022): Aspirin Side Effects
[6] Exclusivity expiration dates are subject to change and may vary depending on regulatory approvals. For the most up-to-date information, refer to DrugPatentWatch.com